Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Zepp Health (ZEPP) Other Operating Expenses (2016 - 2025)

Zepp Health has reported Other Operating Expenses over the past 10 years, most recently at -$15.9 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses fell 20.21% year-over-year to -$15.9 million; the TTM value through Dec 2025 reached -$53.8 million, down 15.73%, while the annual FY2025 figure was $53.8 million, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2025 was -$15.9 million at Zepp Health, down from -$12.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $86.5 million in Q2 2021 and troughed at -$18.1 million in Q4 2022.
  • A 5-year average of $6.3 million and a median of -$11.9 million in 2023 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 756.13% in 2021 and later tumbled 125.98% in 2022.
  • Year by year, Other Operating Expenses stood at $73.6 million in 2021, then plummeted by 124.64% to -$18.1 million in 2022, then skyrocketed by 33.93% to -$12.0 million in 2023, then dropped by 10.57% to -$13.3 million in 2024, then fell by 20.21% to -$15.9 million in 2025.
  • Business Quant data shows Other Operating Expenses for ZEPP at -$15.9 million in Q4 2025, -$12.0 million in Q3 2025, and -$12.0 million in Q2 2025.